Nicole Sweeny, Chief Commercial Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 7,626 shares at $13.45 ($103K) on 2025-11-24, disclosed to the SEC on 2025-12-04.
Open-market sale of $103k KALV by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.45 | 3,813 | $51K | 50.0% |
| 2 | $13.45 | 3,813 | $51K | 50.0% |
| Total | $13.45 avg | 7,626 | $103K | 100% |
| Filing → |
| KALV | SELL | 2026-04-20 | $38K | — | Filing → |
| KALV | SELL | 2026-02-24 | $124K | — | Filing → |
| KALV | SELL | 2025-08-26 | $20K | — | Filing → |